Lünan Yan

机构：China Medical University, Sichuan University, West China Hospital of Sichuan University, China Medical University Hospital

发表论文 368 篇 · 总被引 7796 次 · h-index 38

代表论文

• Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 263)
• Potential Effects of Coronaviruses on the Liver: An Update (2021 · Frontiers in Medicine · 被引 57)
• Sarcopenia defined by psoas muscle index independently predicts long-term survival after living donor liver transplantation in male recipients (2021 · Quantitative Imaging in Medicine and Surgery · 被引 31)
• The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China (2019 · Cancer Epidemiology Biomarkers & Prevention · 被引 31)
• A randomized controlled trial of effect of 15- or 25-minute intermittent Pringle maneuver on hepatectomy for hepatocellular carcinoma (2021 · Surgery · 被引 22)
• Comparison of Hepatic Resection Combined with Intraoperative Radiofrequency Ablation, or Hepatic Resection Alone, for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the University of California San Francisco (UCSF) Criteria: A Propensity Score-Matched Analysis (2020 · Annals of Surgical Oncology · 被引 18)